Showing results (231-240 of 369) with videos related to
Sort By:
Pageof 37
Anticancer Research|December 29, 2018
Gemcitabine Re-challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected PatientsAna Sebio, Anastasia Constantinidou, Charlotte Benson, et al.Nature Communications|January 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trialRobin L Jones, Roman Groisberg, Jean-Yves Blay, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2017
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus DacarbazineGeorge D Demetri, Patrick Schöffski, Giovanni Grignani, et al.Breast Cancer Research and Treatment|October 4, 2007
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysisKay Savage, Samuel Leung, S Katrina Todd, et al.Immunotherapy Advances|February 23, 2023
Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral bloodNatalie M Edner, Elisavet Ntavli, Lina Petersone, et al.Anticancer Research|October 1, 2021
Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma - A Single Centre Retrospective AnalysisGerard M Walls, Shane H Zaidi, Nicos Fotiadis, et al.Gynecologic Oncology Reports|March 18, 2021
Clinical management and outcomes of primary ovarian leiomyosarcoma - Experience from a sarcoma specialist unitElena Cojocaru, Githmi Palahepitiva Gamage, John Butler, et al.Medical Oncology (Northwood, London, England)|December 28, 2019
Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapyFlorence Chamberlain, Elena Cojocaru, Mariana Scaranti, et al.JCO Global Oncology|July 9, 2020
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare CancersAlannah Smrke, Eugenie Younger, Roger Wilson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancerHeidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.Pageof 37